Picture of PCI Biotech Holding ASA logo

PCIBo — PCI Biotech Holding ASA News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: PCI Biotech Holding Q3 Operating Loss Narrows To NOK 8.4 Million

Nov 13 (Reuters) - PCI Biotech Holding ASA  PCIB.OL :
    * FOCUS IS NOW TO BRING FIMACHEM TO MARKET FOR TREATMENT OF
INOPERABLE BILE DUCT CANCER
    * Q3 OPERATING LOSS NOK 8.4  MILLION VERSUS LOSS NOK 10.5
MILLION
YEAR AGO

Source text for Eikon:  ID:nGNEF5XcZ 
Further company coverage:  PCIB.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))

Recent news on PCI Biotech Holding ASA

See all news